Position in TGTX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$8,272,610
+$257,447 QoQ
Shares Held
249,025
-7.4% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
6.50%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ACT CAPITAL MANAGEMENT, LLC holds $76,499,907 across 26 Biotechnology names. TGTX ranks #3 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
60,477 | $15,622,418 | |
| 2 | CELC |
Celcuity Inc.
|
91,675 | $10,463,784 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
This page
|
249,025 | $8,272,610 | |
| 4 | ABVX |
Abivax S.A.
|
70,900 | $7,894,715 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
209,300 | $6,810,622 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
82,500 | $5,172,750 | |
| 7 | NKTR |
Nektar Therapeutics
|
70,900 | $5,101,255 | |
| 8 | CYTK |
Cytokinetics Inc
|
64,500 | $4,251,195 |
All Filings in TGTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,272,610 | 249,025 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $8,015,163 | 268,875 | Shares | Sole | 2026-02-17 | |
| 2021-12-31 | $644,100 | 33,900 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,996,800 | 60,000 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,133,450 | 55,000 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||